PG vs. PASG
PG (The Procter & Gamble Company) and PASG (Passage Bio, Inc.) are both stocks. PG operates in Household & Personal Products (Consumer Defensive), while PASG operates in Biotechnology (Healthcare). Over the past 5 years, PG returned 4.73%/yr vs -54.00%/yr for PASG. At a 0.03 correlation, their price movements are largely independent.
Performance
PG vs. PASG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PG achieves a 5.93% return, which is significantly higher than PASG's -50.76% return.
PG
- 1D
- 0.86%
- 1M
- 5.18%
- YTD
- 5.93%
- 6M
- 6.28%
- 1Y
- -5.68%
- 3Y*
- 3.69%
- 5Y*
- 4.73%
- 10Y*
- 8.96%
PASG
- 1D
- 3.75%
- 1M
- 5.25%
- YTD
- -50.76%
- 6M
- -40.68%
- 1Y
- -32.71%
- 3Y*
- -32.32%
- 5Y*
- -54.00%
- 10Y*
- —
PG vs. PASG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PG The Procter & Gamble Company | 5.93% | -12.26% | 17.25% | -0.86% | -5.05% | 20.52% | 24.88% |
PASG Passage Bio, Inc. | -50.76% | 4.04% | -43.85% | -26.81% | -78.27% | -75.17% | 14.82% |
Correlation
The correlation between PG and PASG is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.03 |
Fundamentals
PG:
$361.53B
PASG:
$18.63M
PG:
$5.23
PASG:
-$11.85
PG:
6.70
PASG:
1.58
PG:
$86.72B
PASG:
$0.00
PG:
$43.64B
PASG:
-$377.00K
PG:
$22.63B
PASG:
-$35.03M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PG vs. PASG — Risk / Return Rank
PG
PASG
PG vs. PASG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Procter & Gamble Company (PG) and Passage Bio, Inc. (PASG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PG | PASG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.77 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.06 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.37 | -0.41 | +0.05 |
| Martin ratioReturn relative to average drawdown | -0.68 | -0.77 | +0.09 |
Loading charts...
Drawdowns
PG vs. PASG - Drawdown Comparison
The maximum PG drawdown since its inception was -54.25%, smaller than the maximum PASG drawdown of -99.43%. Use the drawdown chart below to compare losses from any high point for PG and PASG.
Loading charts...
Drawdown Indicators
| PG | PASG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.25% | -99.43% | +45.18% |
Max Drawdown (1Y)Largest decline over 1 year | -15.52% | -79.45% | +63.93% |
Max Drawdown (3Y)Largest decline over 3 years | -21.15% | -88.21% | +67.06% |
Max Drawdown (5Y)Largest decline over 5 years | -23.77% | -98.69% | +74.92% |
Max Drawdown (10Y)Largest decline over 10 years | -23.77% | — | — |
Current DrawdownCurrent decline from peak | -13.29% | -99.19% | +85.90% |
Average DrawdownAverage peak-to-trough decline | -12.16% | -82.82% | +70.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.80% | 42.35% | -33.55% |
Volatility
PG vs. PASG - Volatility Comparison
The current volatility for The Procter & Gamble Company (PG) is 6.99%, while Passage Bio, Inc. (PASG) has a volatility of 17.49%. This indicates that PG experiences smaller price fluctuations and is considered to be less risky than PASG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PG | PASG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.99% | 17.49% | -10.50% |
Volatility (6M)Calculated over the trailing 6-month period | 15.01% | 100.45% | -85.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.78% | 122.61% | -103.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.82% | 100.91% | -83.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.05% | 99.26% | -80.21% |
Dividends
PG vs. PASG - Dividend Comparison
PG's dividend yield for the trailing twelve months is around 2.85%, while PASG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PASG Passage Bio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PG The Procter & Gamble Company | 2.85% | 2.91% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.31% |
Financials
PG vs. PASG - Financials Comparison
This section allows you to compare key financial metrics between The Procter & Gamble Company and Passage Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PG and PASG have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PASG has higher volatility (17.49%) compared to PG (6.99%). In terms of maximum drawdown, PG dropped -54.25% vs PASG's -99.43%.
PASG currently has the higher Sharpe Ratio (-0.27 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PG and PASG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer